PAZOPANIB HYDROCHLORIDE vs VOTRIENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Attribute	PAZOPANIB HYDROCHLORIDE	VOTRIENT
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	PAZOPANIB HYDROCHLORIDE	PAZOPANIB HYDROCHLORIDE
Manufacturer	Novugen	Novartis
Dosage forms	Tablet	Tablet
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Renal Cell Carcinoma, Soft Tissue Neoplasms	Renal Cell Carcinoma, Soft Tissue Neoplasms

pazopanib hydrochloride votrient

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

PAZOPANIB HYDROCHLORIDE

Manufacturer

Novugen

Novartis

Dosage forms

Tablet

Drug class

—

Boxed warning

Treats

Renal Cell Carcinoma, Soft Tissue Neoplasms

Frequently asked questions

What is the difference between Pazopanib Hydrochloride and Votrient?

Both Pazopanib Hydrochloride and Votrient share the active ingredient Pazopanib Hydrochloride.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.